Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12
A recent study shows that induction of autophagy by STF-62247 increases sensitivity of RCC under hypoxic conditions to radiation in a VHL-dependent manner
potent NS3/4A protease inhibitor for the oral treatment of HCV infection
InChi: InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H
OAC1 seems to enhance reprogramming efficiency in a unique manner
TAK-779 Catalog No.:M10030-10 13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12TAK 779 is a C C chemokine receptor type 5 (CCR5) receptor antagonist potentially for the treatment of HIV infection. Treatment with TAK 779 reduced incidence and severity of experimental autoimmune encephalomyelitis. It strongly inhibited migration of CXCR3 CCR5 bearing CD4+, CD8+ and CD11b+ leukocytes to the CNS. TAK 779 did not reduce proliferation of anti myelin oligodendrocyte glycoprotein T cells, the production of IFN gamma by T cells or CXCR3
US$ 22.00
US$ 30.00
US$ 25.00
US$ 172.00
US$ 43.00
US$ 32.00
US$ 26.95
US$ 22.95
US$ 22.95